Cargando…

High secondary attack rate and persistence of SARS-CoV-2 antibodies in household transmission study participants, Finland 2020–2021

BACKGROUND: Household transmission studies offer the opportunity to assess both secondary attack rate (SAR) and persistence of SARS-CoV-2 antibodies over time. METHODS: In Spring 2020, we invited confirmed COVID-19 cases and their household members to four visits, where we collected nasopharyngeal a...

Descripción completa

Detalles Bibliográficos
Autores principales:	Dub, Timothée, Solastie, Anna, Hagberg, Lotta, Liedes, Oona, Nohynek, Hanna, Haveri, Anu, Virta, Camilla, Vara, Saimi, Lasander, Mervi, Ekström, Nina, Österlund, Pamela, Lind, Katja, Valtonen, Hanna, Hemmilä, Heidi, Ikonen, Niina, Lukkarinen, Timo, Palmu, Arto A., Melin, Merit
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Medicine
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9366099/ https://www.ncbi.nlm.nih.gov/pubmed/35966873 http://dx.doi.org/10.3389/fmed.2022.876532

Ejemplares similares

Persistence of neutralizing antibodies a year after SARS‐CoV‐2 infection in humans
por: Haveri, Anu, et al.
Publicado: (2021)

Neutralizing antibodies to SARS‐CoV‐2 Omicron variant after third mRNA vaccination in health care workers and elderly subjects
por: Haveri, Anu, et al.
Publicado: (2022)

Strong Neutralizing Antibody Responses to SARS-CoV-2 Variants Following a Single Vaccine Dose in Subjects With Previous SARS-CoV-2 Infection
por: Ekström, Nina, et al.
Publicado: (2022)

Changes in SARS-CoV-2 seroprevalence and population immunity in Finland, 2020–2022
por: Solastie, Anna, et al.
Publicado: (2023)

Impaired immunity and high attack rates caused by SARS‐CoV‐2 variants among vaccinated long‐term care facility residents
por: Obach, Dorothée, et al.
Publicado: (2022)

A Highly Sensitive and Specific SARS-CoV-2 Spike- and Nucleoprotein-Based Fluorescent Multiplex Immunoassay (FMIA) to Measure IgG, IgA, and IgM Class Antibodies
por: Solastie, Anna, et al.
Publicado: (2021)

Detection of SARS-CoV-2 Infection in Gargle, Spit, and Sputum Specimens
por: Poukka, Eero, et al.
Publicado: (2021)

Learning about COVID-19-related stigma, quarantine and isolation experiences in Finland
por: Lohiniva, Anna-Leena, et al.
Publicado: (2021)

T cell immunity following COVID-19 vaccination in adult patients with primary antibody deficiency – a 22-month follow-up
por: Hurme, Antti, et al.
Publicado: (2023)

Persistent T cell-mediated immune responses against Omicron variants after the third COVID-19 mRNA vaccine dose
por: Belik, Milja, et al.
Publicado: (2023)

Mid-season real-time estimates of seasonal influenza vaccine effectiveness in persons 65 years and older in register-based surveillance, Stockholm County, Sweden, and Finland, January 2017
por: Hergens, Maria-Pia, et al.
Publicado: (2017)

Register-Based Ecologic Evaluation of Safety Signals Related to Pneumococcal Conjugate Vaccine in Children
por: Artama, Miia, et al.
Publicado: (2018)

Long-Lasting T Cell Responses in BNT162b2 COVID-19 mRNA Vaccinees and COVID-19 Convalescent Patients
por: Hurme, Antti, et al.
Publicado: (2022)

COVID-19 outbreak at a reception centre for asylum seekers in Espoo, Finland
por: Turunen, T., et al.
Publicado: (2021)

Effectiveness of the live attenuated and the inactivated influenza vaccine in two-year-olds – a nationwide cohort study Finland, influenza season 2015/16
por: Nohynek, Hanna, et al.
Publicado: (2016)

Impact of Ten-Valent Pneumococcal Conjugate Vaccination on Invasive Pneumococcal Disease in Finnish Children – A Population-Based Study
por: Jokinen, Jukka, et al.
Publicado: (2015)

High vaccine effectiveness against severe COVID-19 in the elderly in Finland before and after the emergence of Omicron
por: Baum, Ulrike, et al.
Publicado: (2022)

Impact of ten-valent pneumococcal conjugate vaccine on pneumonia in Finnish children in a nation-wide population-based study
por: Palmu, Arto A., et al.
Publicado: (2017)

Cohort study of Covid-19 vaccine effectiveness among healthcare workers in Finland, December 2020 - October 2021
por: Poukka, Eero, et al.
Publicado: (2022)

Serological and molecular findings during SARS-CoV-2 infection: the first case study in Finland, January to February 2020
por: Haveri, Anu, et al.
Publicado: (2020)

Underreporting of SARS-CoV-2 infections during the first wave of the 2020 COVID-19 epidemic in Finland—Bayesian inference based on a series of serological surveys
por: Nieminen, Tuomo A., et al.
Publicado: (2023)

An outbreak caused by the SARS-CoV-2 Delta variant (B.1.617.2) in a secondary care hospital in Finland, May 2021
por: Hetemäki, Iivo, et al.
Publicado: (2021)

Incidence of sinus thrombosis with thrombocytopenia—A nation-wide register study
por: Hovi, Petteri, et al.
Publicado: (2023)

Health professionals’ competencies regarding breastfeeding beyond 12 months: a systematic review
por: Ojantausta, Oona, et al.
Publicado: (2023)

SARS-CoV-2 population-based seroprevalence studies in Europe: a scoping review
por: Grant, Rebecca, et al.
Publicado: (2021)

Clinical validation of automated and rapid mariPOC SARS-CoV-2 antigen test
por: Koskinen, Juha M., et al.
Publicado: (2021)

Immunisation of healthcare workers in the Nordic countries: Variation in recommendations and practices and a lack of assessment
por: Dub, Timothee, et al.
Publicado: (2021)

Highly pathogenic avian influenza A(H5N1) virus infection on multiple fur farms in the South and Central Ostrobothnia regions of Finland, July 2023
por: Lindh, Erika, et al.
Publicado: (2023)

Selection in the Finnhorse, a native all‐around horse breed
por: Kvist, Laura, et al.
Publicado: (2020)

Classification of head and neck cancer from PET images using convolutional neural networks
por: Hellström, Henri, et al.
Publicado: (2023)

No country or continent is on its own in the ongoing COVID-19 pandemic
por: Johansen, Kari, et al.
Publicado: (2021)

DNA-Templated N(Me)-Alkoxyamine Glycosylation
por: Österlund, Tommi, et al.
Publicado: (2018)

Does the World Still Need New Covid-19 Vaccines?
por: Nohynek, Hanna, et al.
Publicado: (2022)

Smoking cessation intervention prior to orthopedic surgery: A study protocol to determine patient outcomes and feasibility
por: Kainiemi, Kalle, et al.
Publicado: (2022)

Outbreak of invasive pneumococcal disease among shipyard workers, Turku, Finland, May to November 2019
por: Linkevicius, Marius, et al.
Publicado: (2019)

Evaluation of the indirect impact of the 10-valent pneumococcal Haemophilus influenzae protein D conjugate vaccine in a cluster-randomised trial
por: Rinta-Kokko, Hanna, et al.
Publicado: (2022)

Culture of all sputum samples irrespective of quality adds value to the diagnosis of pneumococcal community-acquired pneumonia in the elderly
por: Saukkoriipi, Annika, et al.
Publicado: (2019)

Intrasinusoidal proerythroblast infiltration in therapy related myeloid neoplasm
por: Li, Jian, et al.
Publicado: (2023)

Global control of infectious diseases by vaccination programs
por: Tangermann, Rudolf H., et al.
Publicado: (2007)

Genomic and epidemiological report of the recombinant XJ lineage SARS-CoV-2 variant, detected in northern Finland, January 2022
por: Lindh, Erika, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_rvfh08mulfc03757tud5oundl3